Press releases
- Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
- Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
- Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
- Senseonics Holdings, Inc. to Participate in Upcoming Conferences
- Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
- Eversense® CGM System Receives iCGM Designation by the US FDA
- Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
- Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
- Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
As of last trade, Senseonics Holdings Inc (6L6:DUS) traded at 0.402, 14.79% above the 52 week low of 0.3502 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.402 |
---|---|
High | 0.402 |
Low | 0.402 |
Bid | 0.402 |
Offer | 0.4165 |
Previous close | 0.4073 |
Average volume | 919.43 |
---|---|
Shares outstanding | 530.89m |
Free float | 504.62m |
P/E (TTM) | -- |
Market cap | 235.71m USD |
EPS (TTM) | -0.1354 USD |
Data delayed at least 15 minutes, as of May 27 2024 07:13 BST.
More ▼